BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
19,454,185
Share change
+263,666
Total reported value
$5,456,458,314
Put/Call ratio
55%
Price per share
$280.39
Number of holders
385
Value change
+$100,299,144
Number of buys
177
Number of sells
185

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2025

As of 30 Sep 2025, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 385 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,454,185 shares. The largest 10 holders included First Eagle Investment Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, Veritas Asset Management LLP, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, STATE STREET CORP, BANK OF AMERICA CORP /DE/, and Capital Research Global Investors. This page lists 385 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.